Abstract
The relation between post-percutaneous transluminal balloon angioplasty (post-PTCA) and angiography indexes were investigated in the Lovastatin Restenosis Trial. Post-PTCA percent diameter measured by the operator was found to be a weak predictor of angiographic and clinical follow-up restenosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angioplasty, Balloon, Coronary*
-
Anticholesteremic Agents / therapeutic use
-
Constriction, Pathologic
-
Coronary Disease / drug therapy
-
Coronary Disease / therapy*
-
Humans
-
Lovastatin / therapeutic use
-
Randomized Controlled Trials as Topic
-
Recurrence
-
Treatment Outcome
Substances
-
Anticholesteremic Agents
-
Lovastatin